Omalizumab 'relieves' aspirin-exacerbated respiratory disease

Small crossover study results suggest drug might be an important therapeutic candidate, researchers say

Omalizumab reduces aspirin hypersensitivity and lowers leukotriene E4 levels in patients with aspirin-exacerbated respiratory disease (AERD), according to results of a small study.